Cancer Genes, Tumor Suppressors & Proto-oncogenes

SEO Title: Cancer Genes, TSGs & Proto-oncogenes | Joyful CSIR-NET Notes

Search Meta Description: Have fun mastering Cancer Genetics for CSIR NET Life Sciences! High-yield notes on Proto-oncogenes, Tumor Suppressor Genes, Two-Hit Hypothesis, Gatekeeper genes, and Molecular Diagnosis.

CELL COMMUNICATION & SIGNALLING
Chapter 7: Cancer Genes, Tumor Suppressors & Proto-oncogenes

Welcome to Chapter 7! You are on the final stretch of Cancer Biology!
Cancer is fundamentally a disease of the genome. In this chapter, we will master the delicate balance between the "Gas Pedals" (Proto-oncogenes) and the "Brakes" (Tumor Suppressor Genes). Examiners love to test Knudson's Two-Hit Hypothesis and the molecular differences between Gain-of-Function and Loss-of-Function mutations. We have organized these complex genetics into beautiful, high-yield tables and custom SVG diagrams. Let's conquer this!

Quick Navigation Index

• 1. Introduction to Cancer Genes
• 2. Proto-oncogenes & Mechanisms of Activation
• 3. High-Yield Examples of Proto-oncogenes
• 4. Tumor Suppressor Genes (TSGs) & The Two-Hit Hypothesis
• 5. High-Yield Examples of TSGs
• 6. Gatekeeper vs. Caretaker & Driver vs. Passenger
• 7. Gene Expression Patterns & Molecular Diagnosis
• 8. High-Yield CSIR-NET / GATE Memory Tricks
• 9. Fun & High-Yield Master Quiz!

---

1. Introduction to Cancer Genes

Cancer develops primarily due to mutations in three massive classes of regulatory genes:

Cancer Genes
↓
[1] Proto-oncogenes: Normally promote cell growth. (Mutate → Uncontrolled Growth)
[2] Tumor Suppressor Genes: Normally halt the cell cycle. (Mutate → Brakes Fail)
[3] DNA Repair Genes: Normally fix genome damage. (Mutate → Massive Genomic Instability)

---

2. Proto-oncogenes & Mechanisms of Activation

A Proto-oncogene is a perfectly normal, essential cellular gene that drives cell division, survival, and signal transduction (e.g., normal Ras, normal HER2). When it undergoes a Gain-of-Function mutation, it becomes a hyperactive Oncogene.

How does a Proto-oncogene become an Oncogene? Must Know

1. Point Mutation: A single nucleotide change causes the protein to be permanently "ON". (e.g., RAS mutations in colon cancer). 2. Gene Amplification: The DNA replicates the gene hundreds of times. Normal protein is made, but in massive excess. (e.g., HER2 amplification in breast cancer). 3. Chromosomal Translocation: A gene is moved to a new chromosome, fusing with another gene to create a hyperactive hybrid protein. (e.g., BCR-ABL in Chronic Myeloid Leukemia). 4. Viral Insertion: A retrovirus inserts its powerful promoter right next to the proto-oncogene, driving its expression through the roof.

Figure 1: Proto-oncogenes can be converted into lethal Oncogenes by Point Mutations, Gene Amplification, or Translocation.

---

3. High-Yield Examples of Proto-oncogenes

Oncogene	Protein Function	Associated Cancer & Note
RAS	GTPase (Signal Transduction)	Most frequently mutated oncogene. Locked in the active GTP-bound state. (Colon/Pancreatic Cancer).
MYC	Master Transcription Factor	Drives ribosome synthesis and cell cycle. Associated with Burkitt Lymphoma.
HER2 (ERBB2)	Receptor Tyrosine Kinase (RTK)	Amplified in 20-30% of Breast Cancers. Treated directly with the antibody drug Trastuzumab (Herceptin).
BCR-ABL	Non-Receptor Tyrosine Kinase	Created by the Philadelphia Chromosome t(9;22) translocation. Causes CML. Treated with Imatinib.

---

4. Tumor Suppressor Genes (TSGs) & The Two-Hit Hypothesis

If oncogenes are the gas pedal, TSGs are the brakes. They halt the cell cycle to repair DNA, or force apoptosis if the damage is unfixable. Cancer occurs when they suffer a Loss-of-Function mutation.

Knudson's Two-Hit Hypothesis Highly Tested

Because TSGs are protective, having just one working copy (allele) is usually enough to protect the cell. Therefore, both alleles must be mutated (Two Hits) to completely lose the brake and cause cancer.

Hit 1: One allele is mutated (can be inherited, as in familial cancers). Cell is still phenotypically normal. Hit 2: The second, healthy allele is mutated or lost (Loss of Heterozygosity). The cell now has NO brakes → Cancer develops.

Figure 2: The Two-Hit Hypothesis. A single healthy allele is sufficient to keep the cell safe. When the second allele is mutated or deleted (Loss of Heterozygosity), the cell loses its brakes and becomes cancerous.

---

5. High-Yield Examples of TSGs

Tumor Suppressor Gene	Biological Function	Associated Cancer / Disease
TP53	The Guardian of the Genome. Induces DNA repair, cell cycle arrest, or apoptosis.	Mutated in >50% of ALL human cancers. (Li-Fraumeni syndrome if inherited).
RB1	Controls the G1/S Checkpoint by binding and locking the E2F transcription factor.	Retinoblastoma (Eye cancer in children).
APC	Negative regulator of the Wnt/β-catenin pathway. Drives destruction of β-catenin.	Familial Adenomatous Polyposis (FAP) and Colon Cancer.
BRCA1 & BRCA2	Repairs DNA double-strand breaks via Homologous Recombination (HR).	Hereditary Breast and Ovarian Cancer.
PTEN	Phosphatase that inhibits the PI3K-AKT survival pathway (Turns PIP3 back to PIP2).	Endometrial, Prostate, and Breast cancers.

---

6. Gatekeeper vs. Caretaker & Driver vs. Passenger

Gatekeeper vs. Caretaker Genes

• Gatekeepers: Genes that directly regulate cell growth and stop proliferation. (Examples: p53, RB, APC). If they fail, tumors grow immediately.
• Caretakers: Genes that maintain the integrity of the genome by repairing DNA. (Examples: BRCA1, BRCA2, MMR genes). If they fail, mutations accumulate rapidly, eventually hitting a Gatekeeper.

Driver vs. Passenger Mutations Conceptual

• Driver Mutations: The actual functional mutations that give the cancer cell a growth advantage (e.g., RAS mutation). They "drive" the cancer.
• Passenger Mutations: Random background mutations that accumulate as the cancer cell divides wildly. They are biologically neutral and do not contribute to the cancer's growth.

---

7. Gene Expression Patterns & Molecular Diagnosis

Cancer profoundly alters the cell's transcriptome. Certain genes are massively upregulated (turned ON), while others are silenced (turned OFF).

Upregulated (Overexpressed) Genes	Downregulated (Silenced) Genes
MYC, Cyclin D1 (Drives cell cycle)	TP53, RB, p16 (Loss of cell cycle brakes)
VEGF (Drives Angiogenesis)	APC, PTEN (Loss of pathway inhibitors)
BCL-2 (Prevents Apoptosis)	BRCA1, BRCA2 (Loss of DNA repair)
MMPs (Drives Metastasis)	E-Cadherin (Loss of cell adhesion)

Molecular Diagnosis of Cancer

Modern oncology relies on identifying these specific mutations to prescribe targeted therapies. Common techniques include:

• FISH (Fluorescence In Situ Hybridization): Perfect for detecting Chromosomal Translocations (e.g., BCR-ABL) or Amplifications (e.g., HER2).
• Next-Generation Sequencing (NGS): Maps the entire mutational landscape of a tumor simultaneously.
• Liquid Biopsy: Detecting circulating tumor DNA (ctDNA) fragments directly from a simple blood draw!

---

8. High-Yield CSIR-NET / GATE Memory Tricks

Final check! Lock these facts in before your exam! 🚀

• 1. Proto-oncogenes require only ONE mutated allele (Dominant Gain-of-Function) to cause cancer.
• 2. Tumor Suppressor Genes require BOTH alleles to be mutated (Recessive Loss-of-Function) as per Knudson's Two-Hit Hypothesis.
• 3. RAS is the most frequently mutated oncogene, getting locked in the active GTP-bound state.
• 4. The Philadelphia chromosome t(9;22) fuses BCR with ABL, creating a hyperactive kinase causing CML (Treated with Imatinib).
• 5. TP53 (p53) is the Guardian of the Genome, mutated in over half of all cancers.
• 6. RB protein halts the cell cycle at G1/S by locking up the E2F transcription factor.
• 7. APC is a tumor suppressor that destroys β-catenin; its loss leads to colon cancer.
• 8. BRCA1/2 are Caretaker genes responsible for Homologous Recombination (error-free DNA repair).
• 9. Driver mutations actively cause the cancer; Passenger mutations are harmless collateral damage.
• 10. HER2 is an amplified proto-oncogene in breast cancer, treatable with the monoclonal antibody Trastuzumab.

---

9. Fun & High-Yield Master Quiz!

CSIR NET & GATE Master Quiz

Let's test those analytical skills! These 10 questions match the exact logic of high-level life science examinations. You've got this!

1. According to Knudson's Two-Hit Hypothesis, which of the following statements correctly describes the genetics of Tumor Suppressor Genes (TSGs)?

A) A single point mutation in one allele is sufficient to induce malignancy. B) TSGs act in a dominant fashion at the cellular level. C) Both alleles of the gene must suffer loss-of-function mutations for the cell to become cancerous. D) Viral insertion is the only way to inactivate a TSG.

[Correct Answer: C] Exactly! Because TSGs are protective "brakes", as long as the cell has one good brake pad (allele), it can still stop. The cell must lose BOTH alleles (two hits) to completely lose control.

2. The Philadelphia chromosome is a classic cytogenetic hallmark of Chronic Myeloid Leukemia (CML). Which specific molecular event causes this?

A) Gene amplification of the MYC gene. B) A reciprocal translocation between chromosomes 9 and 22, generating the hyperactive BCR-ABL fusion kinase. C) A point mutation in the RAS gene. D) Deletion of the TP53 gene on chromosome 17.

[Correct Answer: B] Spot on! The t(9;22) translocation fuses the BCR and ABL genes. The resulting hybrid protein is a non-stop Tyrosine Kinase that drives massive white blood cell proliferation.

3. In the context of cancer genetics, how is a "Gatekeeper" gene fundamentally distinguished from a "Caretaker" gene?

A) Gatekeepers promote cell division, while Caretakers induce apoptosis. B) Gatekeepers directly inhibit cell growth and proliferation (e.g., RB, p53), whereas Caretakers maintain genome stability by repairing DNA damage (e.g., BRCA1). C) Gatekeepers are proto-oncogenes, and Caretakers are tumor suppressors. D) Gatekeepers are located on the plasma membrane, while Caretakers are exclusively in the nucleus.

[Correct Answer: B] Brilliant! Gatekeepers act as the bouncers of the cell cycle. Caretakers are the mechanics fixing the DNA. Loss of caretakers leads to massive mutation rates, which eventually break the gatekeepers.

4. The drug Trastuzumab (Herceptin) has revolutionized the treatment of a specific subset of breast cancers. What is the direct molecular target of this monoclonal antibody?

A) The VEGF ligand, preventing angiogenesis. B) The BCR-ABL fusion protein inside the cytoplasm. C) The extracellular domain of the amplified HER2 (ERBB2) receptor tyrosine kinase. D) The PD-L1 immune evasion receptor.

[Correct Answer: C] Perfect! Around 20-30% of breast cancers have massive gene amplification of HER2, leading to millions of growth receptors on the cell surface. Trastuzumab binds them from the outside and shuts them down.

5. The Retinoblastoma (RB) protein acts as a critical tumor suppressor. By what specific biochemical mechanism does the active, unphosphorylated RB protein halt the cell cycle?

A) By degrading Cyclin D. B) By binding to and sequestering the E2F transcription factor, preventing the transcription of S-phase genes. C) By acting as a kinase that destroys the DNA replication machinery. D) By directly binding to and inhibiting p53.

[Correct Answer: B] Excellent! RB is the padlock on the G1/S door. It tightly holds onto E2F. The cell cannot replicate its DNA (S-phase) until RB is phosphorylated by CDKs, causing it to let go of E2F.

6. Which of the following mutations would be classified as a "Driver Mutation" during the evolution of a solid tumor?

A) A random, silent mutation in an olfactory (smell) receptor gene in a lung cancer cell. B) A missense mutation in the RAS gene that abolishes its intrinsic GTPase activity, locking it in the ON state. C) A synonymous mutation in a structural keratin gene that does not change the amino acid sequence. D) A mutation acquired purely as a consequence of UV damage that does not alter cell cycle dynamics.

[Correct Answer: B] You nailed it! A driver mutation confers a selective growth advantage to the cell, directly driving cancer progression (like hyperactive RAS). The others are harmless passenger mutations.

7. The APC gene is notoriously mutated in Familial Adenomatous Polyposis (FAP) and sporadic colon cancers. What is the normal function of the APC protein?

A) It is the master regulator of apoptosis. B) It repairs double-strand DNA breaks. C) It functions as a critical scaffold protein in the destruction complex that continuously degrades β-Catenin in the absence of Wnt signaling. D) It phosphorylates Smad proteins in the TGF-β pathway.

[Correct Answer: C] Brilliant! APC is a classic tumor suppressor. If APC is lost, the destruction complex falls apart, β-Catenin builds up massively, enters the nucleus, and drives unchecked colon cell proliferation.

8. What is the fundamental genetic distinction between an inherited (familial) cancer syndrome and a sporadic cancer regarding Tumor Suppressor Genes?

A) Familial cancers are caused by oncogenes, while sporadic cancers are caused by TSGs. B) In familial cancers, the individual is born with one mutated TSG allele in every cell of their body (the first hit), requiring only one somatic mutation (the second hit) to initiate cancer. C) Sporadic cancers only require one mutation to develop. D) Familial cancers cannot be treated with targeted therapies.

[Correct Answer: B] Spot on! This is the essence of Knudson's theory. If you inherit a broken BRCA1 allele from your mother, every cell in your body already has the "first hit". It takes only one random mutation in the remaining allele to trigger cancer, explaining why familial cancers occur earlier in life.

9. A tumor biopsy is subjected to transcriptome microarray analysis. Which of the following gene expression profiles is most characteristic of a highly aggressive, metastatic carcinoma?

A) Upregulation of TP53, Downregulation of MYC, Upregulation of E-Cadherin. B) Upregulation of BRCA1, Upregulation of APC, Downregulation of BCL-2. C) Upregulation of VEGF, Upregulation of MMPs, Downregulation of PTEN. D) Downregulation of Cyclin D1, Upregulation of RB, Downregulation of Telomerase.

[Correct Answer: C] Perfect reasoning! Aggressive cancers need blood (VEGF upregulated), need to chew through tissue to metastasize (MMPs upregulated), and need to survive and ignore death signals (PTEN downregulated).

10. The PTEN protein acts as a crucial tumor suppressor by directly antagonizing which specific pro-survival signaling pathway?

A) The JAK-STAT pathway B) The PI3K-AKT pathway, by dephosphorylating PIP3 back to PIP2. C) The Ras-MAPK cascade, by acting as a GAP for Ras. D) The Notch signaling pathway.

[Correct Answer: B] Exactly! PI3K creates PIP3 to activate the AKT survival/growth pathway. PTEN is the eraser that destroys PIP3, turning the survival signal OFF. Loss of PTEN is a major driver of endometrial, breast, and prostate cancers.